The Vanguard Group Discloses Stake in Mural Oncology plc

The Vanguard Group, Inc. has released a Form 8.3 disclosure revealing their interest in Mural Oncology plc. The disclosure, dated September 5, 2025, is part of compliance with the Irish Takeover Panel rules. The form indicates that Vanguard holds 771,347 ordinary shares of Mural Oncology, accounting for 4.47% of the relevant securities of the company.

No agreements or arrangements regarding options or derivatives have been disclosed, and no indemnity or other dealing arrangements are reported. Furthermore, there have been minor transactions with a sale of 16 ordinary shares at $2.07 USD per share. No cash-settled or stock-settled derivative transactions are mentioned in this disclosure.

This filing is a standard procedure and contributes to transparency during potential takeover activities involving Mural Oncology plc.